journal article·2025-01-01Open access

Role of Nanotechnology in Ischemic Stroke: Advancements in Targeted Therapies and Diagnostics for Enhanced Clinical Outcomes

Virendra Kumar Yadav, Rachna Gupta, Abdullah A. Assiri, Jalal Uddin, Azfar A. Ishaqui, Pankaj Kumar, Khalid M. Orayj, Shazia Tahira, Ashish Patel, Nisha Choudhary

Abstract

Each year, the number of cases of strokes and deaths due to this is increasing around the world. This could be due to work stress, lifestyles, unhealthy food habits, and several other reasons. Currently, there are several traditional methods like thrombolysis and mechanical thrombectomy for managing strokes. The current approach has several limitations, like delayed diagnosis, limited therapeutic delivery, and risks of secondary injuries. So, there is a need for some effective and reliable methods for the management of strokes, which could help in early diagnosis followed by the treatment of strokes. Nanotechnology has played an immense role in managing strokes, and recently, it has emerged as a transformative solution offering innovative diagnostic tools and therapeutic strategies. Nanoparticles (NPs) belonging to several classes, including metallic (metallic and metal oxide), organic (lipids, liposome), and carbon, can cross the blood–brain barrier and may exhibit immense potential for managing various strokes. Moreover, these NPs have exhibited promise in improving imaging specificity and therapeutic delivery by precise drug delivery and real-time monitoring of treatment efficacy. Nanomaterials like cerium oxide (CeO2) and liposome-encapsulated agents have neuroprotective properties that reduce oxidative stress and promote neuroregeneration. In the present article, the authors have emphasized the significant advancements in the nanomedicine management of stroke, including NPs-based drug delivery systems, neuroprotective and neuroregenerative therapies, and multimodal imaging advancements.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Marwadi University Research Center, Department of Microbiology, Faculty of Sciences, Marwadi University, Rajkot 360003, Gujarat, India

Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382021, Gujarat, India

Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61441, Saudi Arabia

Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha 61441, Saudi Arabia

Department of Environmental Science, Parul Institute of Applied Sciences, Parul University, Vadodara 391760, Gujarat, India

Institute of Professional Psychology, Bahria University Karachi Campus, Karachi 75260, Pakistan

Department of Psychiatry, Jinnah Postgraduate Medical Centre, Karachi 75510, Pakistan

Department of Life Sciences, Hemchandracharya North Gujarat University, Patan 384265, Gujarat, India

Department of Lifesciences, Parul Institute of Applied Sciences, Parul University, Vadodara 391760, Gujarat, India

Funding

Deanship of Research and Graduate Studies at King Khalid University

References (100+)

Show source-provided references
1. Advancing Stroke Therapy: Innovative Approaches with Stem Cell-Derived Extracellular Vesicles10.1186/s12964-024-01752-1 ↗
2. Wiyarta, E., Fisher, M., Kurniawan, M., Hidayat, R., Geraldi, I.P., Khan, Q.A., Widyadharma, I.P.E., Badshah, A., and Pandian, J.D. (2024). Global Insights on Prehospital Stroke Care: A Comprehensive Review of Challenges and Solutions in Low- and Middle-Income Countries. J. Clin. Med., 13.10.3390/jcm13164780 ↗
3. Neema, N., Prathibha, R.J., and Sonali, N.M. (2022, January 16–17). Analysis and Classification of Occurrence of Brain Stroke Types Using Machine Learning Approaches. Proceedings of the 2022 IEEE 2nd Mysore Sub Section International Conference (MysuruCon), Mysuru, India.10.1109/MysuruCon55714.2022.9972403 ↗
4. Modi, S., Yadav, V.K., Thakur, R., Kumari, M., Gnanamoorthy, G., Patel, A., Choudhary, N., and Fulekar, M.H. (2024). Comparative Analysis of Morphological and Structural Properties of Zinc Oxide Nanoparticles Synthesized by Sonochemical Method and Microbial Method. Plasmonics.10.1007/s11468-024-02659-w ↗
5. Yoshimoto, T. (2023). Imaging Diagnosis of Intracranial Atherosclerosis Stenosis-Related Large Vessel Occlusion before and during Endovascular Therapy. Front. Neurol., 14.10.3389/fneur.2023.1168004 ↗
6. Jain, M., Patil, D., Gupta, S., and Mahajan, S. (2024). Advancement in Diagnostic and Therapeutic Techniques for Ischemic Stroke. Integrating Metaheuristics in Computer Vision for Real-World Optimization Problems, Wiley.10.1002/9781394230952.ch1 ↗
7. Babenko, V.A., Fedulova, K.S., Silachev, D.N., Rahimi-Moghaddam, P., Kalyuzhnaya, Y.N., Demyanenko, S.V., and Plotnikov, E.Y. (2023). The Role of Matrix Metalloproteinases in Hemorrhagic Transformation in the Treatment of Stroke with Tissue Plasminogen Activator. J. Pers. Med., 13.10.3390/jpm13071175 ↗
8. Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke10.1161/JAHA.123.029817 ↗
9. Challenges to Widespread Implementation of Stroke Thrombectomy10.1161/STROKEAHA.124.045889 ↗
10. Factors Affecting Management of Acute Ischemic Stroke with Reference to Intravenous Thrombolysis and Its Impact on Short Term Outcome10.21275/SR231125142248 ↗
11. Intravenous Thrombolysis for Acute Ischemic Stroke10.1212/CON.0000000000001207 ↗
12. Intracranial Atherosclerotic Disease: Current Management Strategies10.1097/MS9.0000000000001145 ↗
13. The Role of Induced Pluripotent Stem Cells in the Treatment of Stroke10.2174/1570159X22666240603084558 ↗
14. The Role of Stem Cell Therapies in the Treatment of Neurodegenerative Diseases
15. Markowska, A., Koziorowski, D., and Szlufik, S. (2023). Microglia and Stem Cells for Ischemic Stroke Treatment—Mechanisms, Current Status, and Therapeutic Challenges. Front. Biosci.-Landmark, 28.10.31083/j.fbl2810269 ↗
16. Modeling Neurological Disorders Using Brain Organoids10.1016/j.semcdb.2020.05.026 ↗
17. Exploring New Horizons: Emerging Therapeutic Strategies for Pediatric Stroke10.1016/j.expneurol.2024.114701 ↗
18. Kamtchum-Tatuene, J., Nomani, A.Z., Falcione, S., Munsterman, D., Sykes, G., Joy, T., Spronk, E., Vargas, M.I., and Jickling, G.C. (2021). Non-Stenotic Carotid Plaques in Embolic Stroke of Unknown Source. Front. Neurol., 12.10.3389/fneur.2021.719329 ↗
19. The Attributable Risk of Nonstenotic Cervical Carotid Plaque in Cryptogenic Embolic Stroke
20. Symptomatic Non-Stenotic Carotid Disease: Current Challenges and Opportunities for Diagnosis and Treatment10.1136/jnis-2022-020005 ↗
21. Song, H., Wang, Z., Song, W., Shen, Z., Guo, X., and Tian, S. (2023). Stroke. Therapeutics of Neural Stimulation for Neurological Disorders, Springer Nature.10.1007/978-981-99-4538-2_26 ↗
22. Cell Therapy and Functional Recovery of Stroke10.1016/j.neuroscience.2023.11.027 ↗
23. Blood Brain Barrier-Targeted Lipid Nanoparticles Improved the Neuroprotection of Ferrostatin-1 against Cerebral Ischemic Damage in an Experimental Stroke Model10.1016/j.expneurol.2024.114849 ↗
24. Recent Advances in the Applications of Nanotechnology and Nanomaterials in the Petroleum Industry: A Descriptive Review10.1002/ppsc.202300029 ↗
25. Chahar, M., Choudhary, N., Yadav, K.K., Qasim, M.T., Zairov, R., Patel, A., Yadav, V.K., and Jangir, M. (2024). Recent Advances in the Synthesis of Nitrogen-Containing Heterocyclic Compounds via Multicomponent Reaction and Their Emerging Biological Applications: A Review. J. Iran. Chem. Soc.
26. Lipid Engineered Nanomaterials: A Novel Paradigm Shift for Combating Stroke10.1016/j.apmt.2024.102194 ↗
27. Bernardo-Castro, S., Albino, I., Barrera-Sandoval, Á.M., Tomatis, F., Sousa, J.A., Martins, E., Simões, S., Lino, M.M., Ferreira, L., and Sargento-Freitas, J. (2021). Therapeutic Nanoparticles for the Different Phases of Ischemic Stroke. Life, 11.10.3390/life11060482 ↗
28. Liu, W., Liu, L., Li, H., Xie, Y., Bai, J., Guan, J., Qi, H., and Sun, J. (2024). Targeted Pathophysiological Treatment of Ischemic Stroke Using Nanoparticle-Based Drug Delivery System. J. Nanobiotechnol., 22.10.1186/s12951-024-02772-2 ↗
29. Recent Advances in Targeted Nanoparticle Drug Delivery Systems for Ischaemic Stroke10.1039/D3MA00472D ↗
30. Jank, L., Pinto-Espinoza, C., Duan, Y., Koch-Nolte, F., Magnus, T., and Rissiek, B. (2019). Current Approaches and Future Perspectives for Nanobodies in Stroke Diagnostic and Therapy. Antibodies, 8.10.3390/antib8010005 ↗
31. Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies10.1021/acsnano.1c04753 ↗
32. The Integration of Nanomedicine with Traditional Chinese Medicine: Drug Delivery of Natural Products and Other Opportunities10.1021/acs.molpharmaceut.2c00882 ↗
33. Nanomedicine Directs Neuronal Differentiation of Neural Stem Cells via Silencing Long Noncoding RNA for Stroke Therapy10.1021/acs.nanolett.0c04560 ↗
34. Dhuri, K., Vyas, R.N., Blumenfeld, L., Verma, R., and Bahal, R. (2021). Nanoparticle Delivered Anti-MiR-141-3p for Stroke Therapy. Cells, 10.10.3390/cells10051011 ↗
35. Lochhead, J.J., Yang, J., Ronaldson, P.T., and Davis, T.P. (2020). Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders. Front. Physiol., 11.10.3389/fphys.2020.00914 ↗
36. Zedde, M., and Pascarella, R. (2024). The Cerebrovascular Side of Plasticity: Microvascular Architecture across Health and Neurodegenerative and Vascular Diseases. Brain Sci., 14.10.3390/brainsci14100983 ↗
37. Dhapola, R., Medhi, B., and HariKrishnaReddy, D. (2024). Insight into the Pathophysiological Advances and Molecular Mechanisms Underlying Cerebral Stroke: Current Status. Mol. Biol. Rep., 51.10.1007/s11033-024-09597-0 ↗
38. Kuriakose, D., and Xiao, Z. (2020). Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int. J. Mol. Sci., 21.10.3390/ijms21207609 ↗
39. The Role of Nanomaterials in Revolutionizing Ischemic Stroke Treatment: Current Trends and Future Prospects10.1016/j.isci.2024.111373 ↗
40. Wang, Y.-R., Cui, W.-Q., Wu, H.-Y., Xu, X.-D., and Xu, X.-Q. (2023). The Role of T Cells in Acute Ischemic Stroke. Brain Res. Bull.10.1016/j.brainresbull.2023.03.005 ↗
41. A Comparative Study of the Neuroprotective Effects of Dl-3-n-Butylphthalide and Edaravone Dexborneol on Cerebral Ischemic Stroke Rats10.1016/j.ejphar.2023.175801 ↗
42. Ischemia-Reperfusion Injury: Molecular Mechanisms and Therapeutic Targets10.1038/s41392-023-01688-x ↗
43. Deng, J., Liu, Q., Ye, L., Wang, S., Song, Z., Zhu, M., Qiang, F., Zhou, Y., Guo, Z., and Zhang, W. (2024). The Janus Face of Mitophagy in Myocardial Ischemia/Reperfusion Injury and Recovery. Biomed. Pharmacother., 173.10.1016/j.biopha.2024.116337 ↗
44. Zhang, H., Wang, L., Yang, Y., Cai, C., Wang, X., Deng, L., He, B., Zhou, W., and Cui, Y. (2023). DL-3-n-Butylphthalide (NBP) Alleviates Poststroke Cognitive Impairment (PSCI) by Suppressing Neuroinflammation and Oxidative Stress. Front. Pharmacol., 13.10.3389/fphar.2022.987293 ↗
45. Iancu, A., Buleu, F., Chita, D.S., Tutelca, A., Tudor, R., and Brad, S. (2023). Early Hemorrhagic Transformation after Reperfusion Therapy in Patients with Acute Ischemic Stroke: Analysis of Risk Factors and Predictors. Brain Sci., 13.10.3390/brainsci13050840 ↗
46. European Stroke Organisation Guidelines on Treatment of Patients with Intracranial Atherosclerotic Disease10.1177/23969873221099715 ↗
47. Xue, X. (2019). Introduction: Nanomedicine in the Brain. Nanomedicine in Brain Diseases: Principles and Application, Springer.10.1007/978-981-13-8731-9 ↗
48. Treatments in Ischemic Stroke: Current and Future10.1159/000525822 ↗
49. Hematoma Evacuation via Image-Guided Para-Corticospinal Tract Approach in Patients with Spontaneous Intracerebral Hemorrhage10.1007/s40120-021-00279-8 ↗
50. Mangiferin Alleviated Poststroke Cognitive Impairment by Modulating Lipid Metabolism in Cerebral Ischemia/Reperfusion Rats10.1016/j.ejphar.2024.176724 ↗
51. Understanding Ischemic Stroke: Symptoms, Risks, and the Importance of Timely Intervention10.69512/ajphi.v1i2.61 ↗
52. Cerebral Microvessel Responses to Focal Ischemia10.1097/01.WCB.0000078322.96027.78 ↗
53. A Novel Strategy of Integrating Network Pharmacology and Transcriptome Reveals Antiapoptotic Mechanisms of Buyang Huanwu Decoction in Treating Intracerebral Hemorrhage10.1016/j.jep.2023.117123 ↗
54. Structure–Activity Study of Fluorine or Chlorine-substituted Cinnamic Acid Derivatives with Tertiary Amine Side Chain in Acetylcholinesterase and Butyrylcholinesterase Inhibition10.1002/ddr.21515 ↗
55. Shen, W.-C. (2021). Medical Imaging of Cerebral Hemorrhagic Stroke. Diagnostic Neuroradiology, Springer.10.1007/978-981-15-4051-6_4 ↗
56. Loss of M6A Demethylase ALKBH5 Promotes Post-ischemic Angiogenesis via Post-transcriptional Stabilization of WNT5A10.1002/ctm2.402 ↗
57. A Novel Small-Molecule PCSK9 Inhibitor E28362 Ameliorates Hyperlipidemia and Atherosclerosis10.1038/s41401-024-01305-9 ↗
58. Post-Translational Modification of RNA M6A Demethylase ALKBH5 Regulates ROS-Induced DNA Damage Response10.1093/nar/gkab415 ↗
59. Mechanisms of Neuronal Cell Death in Ischemic Stroke and Their Therapeutic Implications10.1002/med.21817 ↗
60. Metabolomics Integrated with Network Pharmacology of Blood-Entry Constituents Reveals the Bioactive Component of Xuefu Zhuyu Decoction and Its Angiogenic Effects in Treating Traumatic Brain Injury10.1186/s13020-024-01001-0 ↗
61. Puy, L., Kuchcinski, G., Leboullenger, C., Auger, F., Cordonnier, C., and Bérézowski, V. (2024). Multimodal and Serial MRI Monitors Brain Peri-Hematomal Injury and Repair Mechanisms after Experimental Intracerebral Hemorrhage. J. Cereb. Blood Flow. Metab.10.1177/0271678X241270198 ↗
62. Poststroke Motor and Cognitive Impairments: Clinical Features and Current Approaches to Rehabilitation10.17116/jnevro202012011199 ↗
63. A Low-Dimensional Structure of Neurological Impairment in Stroke10.1093/braincomms/fcab119 ↗
64. Azhari, H.F. (2024). Advancing Stroke Diagnosis and Management through Nuclear Medicine: A Systematic Review of Clinical Trials. Front. Med., 11.10.3389/fmed.2024.1425965 ↗
65. Neuroimaging of Acute Ischemic Stroke: Multimodal Imaging Approach for Acute Endovascular Therapy10.5853/jos.2022.03286 ↗
66. Performance of Automated RAPID Intracranial Hemorrhage Detection in Real-World Practice: A Single-Institution Experience10.1097/RCT.0000000000001335 ↗
67. Liu, F., Yao, Y., Zhu, B., Yu, Y., Ren, R., and Hu, Y. (2024). The Novel Imaging Methods in Diagnosis and Assessment of Cerebrovascular Diseases: An Overview. Front. Med., 11.10.3389/fmed.2024.1269742 ↗
68. Diffusion-Weighted Imaging: New Paradigm in Diagnosis of Early Acute Pancreatitis10.4103/aam.aam_79_24 ↗
69. Diagnostic Value of Alternative Techniques to Gadolinium-Based Contrast Agents in MR Neuroimaging—A Comprehensive Overview10.1186/s13244-019-0771-1 ↗
70. Core and Penumbra Estimation Using Deep Learning-Based AIF in Association with Clinical Measures in Computed Tomography Perfusion (CTP)10.1186/s13244-023-01472-z ↗
71. Chauvet, G., Cheddad El Aouni, M., Magro, E., Sabardu, O., Ben Salem, D., Gentric, J.-C., and Ognard, J. (2024). Diagnostic Accuracy of Non-Contrast-Enhanced Time-Resolved MR Angiography to Assess Angioarchitectural Classification Features of Brain Arteriovenous Malformations. Diagnostics, 14.10.3390/diagnostics14151656 ↗
72. Clinical Evaluation of a Microwave-Based Device for Detection of Traumatic Intracranial Hemorrhage10.1089/neu.2016.4869 ↗
73. Emerging Technologies in Optimizing Pre-Intervention Workflow for Acute Stroke10.1093/neuros/nyz058 ↗
74. Microwave-Based Stroke Diagnosis Making Global Prehospital Thrombolytic Treatment Possible10.1109/TBME.2014.2330554 ↗
75. V The VITAL Study and Overall Pooled Analysis with the VIPS Non-Invasive Stroke Detection Device10.1136/neurintsurg-2017-013690 ↗
76. Clot-Targeted Nanogels for Dual-Delivery of AntithrombinIII and Tissue Plasminogen Activator to Mitigate Disseminated Intravascular Coagulation Complications10.1021/acsnano.4c00162 ↗
77. Liu, J.S.T., Ding, Y., Schoenwaelder, S., and Liu, X. (2022). Improving Treatment for Acute Ischemic Stroke—Clot Busting Innovation in the Pipeline. Front. Med. Technol., 4.10.3389/fmedt.2022.946367 ↗
78. Erythrocyte Fraction Within Retrieved Thrombi Contributes to Thrombolytic Response in Acute Ischemic Stroke10.1161/STROKEAHA.117.019138 ↗
79. Antiplatelet Use in Ischemic Stroke10.1177/10600280211073009 ↗
80. Zhang, Y.-J., Li, M.-P., Tang, J., and Chen, X.-P. (2017). Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives. Int. J. Environ. Res. Public Health, 14.10.3390/ijerph14030301 ↗
81. Comparison of Non–Stent Retriever and Stent Retriever Mechanical Thrombectomy Devices for the Endovascular Treatment of Acute Ischemic Stroke10.3171/2016.2.JNS152086 ↗
82. Clinical Imaging of the Penumbra in Ischemic Stroke: From the Concept to the Era of Mechanical Thrombectomy10.3389/fcvm.2022.861913 ↗
83. Risk Factors and Mechanism of Hemorrhagic Transformation of Acute Ischemic Cerebral Infarction10.9734/jammr/2022/v34i2131529 ↗
84. Pathophysiology, Management, and Therapeutics in Subarachnoid Hemorrhage and Delayed Cerebral Ischemia: An Overview10.3390/pathophysiology30030032 ↗
85. Stereotactic Hematoma Puncture and Drainage for Primary Pontine Hemorrhage: Clinical Outcomes and Predictive Model10.1016/j.heliyon.2024.e27487 ↗
86. Impact of Stereotactic Hematoma Evacuation on Activities of Daily Living during the Chronic Period Following Spontaneous Putaminal Hemorrhage: A Randomized Study10.3171/jns.2004.101.3.0417 ↗
87. Comparison of Neurological Clinical Manifestation in Patients with Hemorrhagic and Ischemic Stroke10.5847/wjem.j.1920-8642.2017.01.006 ↗
88. Nicotinamide Mononucleotide Protects against High-Fat-Diet-Induced Atherosclerosis in Mice and Dampens Aortic Inflammation and Oxidative Stress10.1016/j.jff.2023.105985 ↗
89. Nursing and Institutional Responsibilities for In-Hospital Stroke10.1161/STROKEAHA.123.042868 ↗
90. Acute Glycemic Variability and Mortality of Patients with Acute Stroke: A Meta-Analysis10.1186/s13098-022-00826-9 ↗
91. Advances in Nanomedicines: A Promising Therapeutic Strategy for Ischemic Cerebral Stroke Treatment10.2217/nnm-2023-0266 ↗
92. Yadav, V.K., Choudhary, N., Inwati, G.K., Rai, A., Singh, B., Solanki, B., Paital, B., and Sahoo, D.K. (2023). Recent Trends in the Nanozeolites-Based Oxygen Concentrators and Their Application in Respiratory Disorders. Front. Med., 10.10.3389/fmed.2023.1147373 ↗
93. Phytofabrication of Silver Nanoparticles by Using Cucurbita maxima Leaf Extract and Its Potential Anticancer Activity and Pesticide Degradation10.1080/10667857.2024.2440907 ↗
94. Application of Nanotechnology-Based Products in Stroke10.1021/acschemneuro.2c00804 ↗
95. Modified Nanoparticles for the Diagnosis and Treatment of Ischemic Stroke10.54254/2753-8818/4/20220538 ↗
96. New Opportunities for Theranostics Research in Stroke10.54779/chl20240625 ↗
97. Li, Y., Wu, C., Yang, R., Tang, J., Li, Z., Yi, X., and Fan, Z. (2024). Application and Development of Cell Membrane Functionalized Biomimetic Nanoparticles in the Treatment of Acute Ischemic Stroke. Int. J. Mol. Sci., 25.10.3390/ijms25158539 ↗
98. A Minimalist Iron Oxide Nanoprobe for the High-Resolution Depiction of Stroke by Susceptibility-Weighted Imaging10.1002/smll.202401061 ↗
99. Imaging of Acute Stroke and Transient Ischaemic Attack10.1136/jnnp.2005.075168 ↗
100. Ferumoxytol: An Emerging Therapeutic for Iron Deficiency Anemia10.1080/14656566.2022.2150545 ↗